Further investigations into differentially expressed proteins in non-malignant and type I and II endometrial cancer samples using iTRAQ identified 1387 proteins, with 3 novel candidates suggested: WFDC2, CLU, and MUC5B [31]. This evidence concerns the gene CLU and endometrial cancer.